Heartcore Capital

Heartcore Capital is an early-stage venture capital firm founded in 2007 and based in Copenhagen, Denmark, with additional offices in Berlin and Paris. The firm focuses on investing in seed-stage and early-stage companies, primarily in the information technology, healthcare, and technology-based sectors across Europe. Heartcore Capital has raised approximately €770 million in committed capital through multiple funds, including early-stage, growth-opportunity, and web3 funds. With a diverse team that encompasses nine nationalities and speaks ten languages, Heartcore aims to support exceptional founders in building category-defining consumer internet brands. The firm has invested in over 100 founding teams from 13 countries, backing notable companies such as Tink, Neo4j, and TravelPerk.

Claus A. Andersson

General Partner

Levin Bunz

Partner

Yacine Ghalim

Partner

Lærke Rud Hansen

Principal

Christian Jepsen

Partner

Paulina Koschitz

Principal

Soren Lemonius

Co-Founder and Managing General Partner

Jacob Lange Moresco

Investment Director

Jimmy Nielsen

Partner and Co-Founder

Björn Nilsen

Principal

Yohan Pereira

Investor

Thomas Thestrup

Associate

Sten Verland

Co-Founder and General Partner

262 past transactions

IXI

Series A in 2025
IXI modernizes traditional eyeglass optics by introducing a pioneering adaptive solution giving anyone perfect vision.

PhaseTree

Seed Round in 2025
PhaseTree provides a comprehensive picture of material behavior that is not possible with conventional single-scale methods, providing previously unheard-of insights.

Superform Labs

Venture Round in 2024
Superform is a non-custodial yield marketplace. The protocol enables access to Erc-4626 vaults using any Evmchain.

Barter

Seed Round in 2024
Barter enables decentralized applications by ensuring efficient transaction routing and optimization.

Luca

Seed Round in 2024
Luca's learning platform provides learning programs for primary and secondary Spanish Speaking Latin American school students. The learning platform offers pre-recorded K12 videos, gamified content and AI powered personalized study paths, covering the entire official academic curriculum and national exams prep. Luca is a VC backed startup with HQ in Mexico City, Lisbon & Madrid

Rhinestone

Seed Round in 2024
Rhinestone is building a platform to enable a secure ecosystem of smart account modules and, with it, permissionless wallet innovation.

Byway Travel

Series A in 2024
Byway Travel provides slow travel trips that take the scenic route to local stays, off-the-beaten-path experiences.

Skynopy

Pre Seed Round in 2024
Skynopy is a provider of satellite connection services designed to facilitate communication between satellite operators and their satellites in Low-Earth Orbit. The company offers transmission kits and maintains a network of ground stations to ensure reliable and secure communication. By enabling efficient and dependable data transmission capabilities, Skynopy supports satellite operators in managing their operations effectively.

Natural Cycles

Series C in 2024
Natural Cycles is a digital health company that provides a contraceptive app designed to empower women in managing their reproductive health. The app utilizes an algorithm to analyze users' basal body temperature and other relevant data, such as luteinizing hormone levels, to determine fertility status throughout the menstrual cycle. By requiring daily temperature measurements with a basal thermometer, the app generates a color-coded calendar that informs users of their fertile days, allowing for informed decisions regarding unprotected sex. This non-invasive and non-hormonal approach enables women to plan or prevent pregnancies while avoiding the side effects associated with traditional contraceptive methods. Natural Cycles is at the forefront of digital contraception, offering a modern solution to female fertility tracking.

MAJORITY

Series B in 2024
MAJORITY is a fintech company that provides an app-based platform tailored for migrants seeking accessible financial services. For a monthly fee, members in the United States gain access to essential banking features, including an FDIC-secured account and a VISA debit card. The platform allows users to utilize over 55,000 ATMs across North America and offers services such as remittances, international calling, and mobile top-ups. Additionally, MAJORITY emphasizes community engagement by providing access to local meet-up spaces, discounts, and events, along with support from advisors fluent in various native languages. This comprehensive approach aims to address the unique financial needs of individuals who have crossed borders.

Hylé

Seed Round in 2024
Hylé is the modular ZK stack's core layer, providing a secure, decentralized, and censorship-resistant settlement layer for all ZK proofs.

FlexAI

Seed Round in 2024
Unlocking the future of Machine Intelligence by rearchitecting the compute infrastructure

Zefir

Venture Round in 2024
Zefir operates an online real estate marketplace designed to simplify the buying and selling of properties. By utilizing advanced valuation algorithms and automated processes, Zefir allows sellers to receive offers for their homes without the need for traditional listing or showing. This streamlined approach aims to make transactions more straightforward and efficient for customers, facilitating a simple and certain experience in real estate dealings.

Orbex Space

Series C in 2024
Founded in 2015, Orbex is a leading private launch services company in Europe, specializing in the small satellite industry. The company has developed a low carbon, high-performance micro-launch vehicle that supports the deployment of satellites into polar and sun-synchronous low Earth orbits from a modern launch site in central Europe. Orbex offers a flexible core launch service along with a range of supporting services aimed at simplifying the launch process for its customers. By operating from a European location, Orbex benefits from shorter supply lines, easier communication, and reduced operational costs. The company utilizes advanced materials and in-house technologies, including rocket engines and avionics, to ensure high reliability and flexible mission profiles, enabling timely launches for small, micro, and nano-satellites.

La Fourche

Series B in 2024
At La Fourche we believe healthy consumption should be affordable to everyone and our mission is to offer everyday organic products to "the 99%". Based on a a subscription model, our platform offers thousands of organic products with up to 50% discount and allows families to reduce up their spending up to 1000€. Join us!

Resalis Therapeutics

Series A in 2024
Resalis Therapeutics is a biopharmaceutical company focused on transforming the treatment of metabolic diseases, particularly obesity and fatty liver disease, by developing innovative therapies that target key regulatory pathways. The company's leading program, RES-010, utilizes its expertise in non-coding RNA drug modalities and lipid metabolism to create a treatment that aims for long-term weight loss and reduced liver fat accumulation. With a strong foundation of preclinical evidence, Resalis is progressing RES-010 into clinical trials, offering potential disease-modifying effects and a safe, convenient therapeutic option for patients suffering from various metabolic disorders.

Quesma

Pre Seed Round in 2023
Quesma is a technology company focused on assisting businesses in transitioning from outdated database platforms to modern solutions. Its core product, a database gateway, serves as a compatibility and translation layer that enables development teams to modernize their application architectures. By introducing this smart gateway between applications and database engines, Quesma helps companies unbundle their application stacks from legacy systems, mitigating the risks and costs associated with migration. This approach allows businesses to take advantage of the scalability, performance, and cost-efficiency offered by contemporary databases while preserving their existing application investments. Ultimately, Quesma aims to streamline the modernization process for organizations seeking to innovate and remain competitive in an evolving technological landscape.

Rhinestone

Pre Seed Round in 2023
Rhinestone is building a platform to enable a secure ecosystem of smart account modules and, with it, permissionless wallet innovation.

Panoptic

Seed Round in 2023
Panoptic is a perpetual, oracle-free, instant-settlement options trading protocol on the Ethereum blockchain. Panoptic enables the permissionless trading of options on top of any asset pool in the Uniswap v3 ecosystem and seeks to develop a trustless, permissionless, and composable options product, i.e., do for decentralized options markets what x*y=k automated market maker protocols did for spot trading. Offering advanced solutions for trading, liquidity provision, and risk management, the company caters to various strategies and roles in the DeFi ecosystem.

Nūmi

Pre Seed Round in 2023
Nūmi mission to redefine health through groundbreaking research making the unparalleled benefits of breast milk accessible to all.

Kynexis

Series A in 2023
Kynexis is focused on developing a precision medicine aimed at treating cognitive impairment associated with schizophrenia (CIAS). The company's innovative research utilizes a human biology-based approach to identify causal biomarkers that inform its mechanism of action during clinical development. Additionally, Kynexis employs a human genetics strategy to pinpoint specific sub-populations of patients who are likely to respond positively to the treatment. Through these methods, Kynexis seeks to enhance brain function in individuals affected by schizophrenia, addressing a critical need in mental health care.

La Fourche

Series B in 2023
At La Fourche we believe healthy consumption should be affordable to everyone and our mission is to offer everyday organic products to "the 99%". Based on a a subscription model, our platform offers thousands of organic products with up to 50% discount and allows families to reduce up their spending up to 1000€. Join us!

MinervaX

Venture Round in 2023
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.

Likeminded

Seed Round in 2023
Likeminded is a digital platform focused on mental health, offering a variety of courses aimed at enhancing mental well-being. The platform provides both individual and group sessions, along with on-demand support, to meet the diverse needs of users. Trained psychotherapists, psychologists, and coaches deliver these services, ensuring a comprehensive approach to mental health care. The experts at Likeminded possess academic backgrounds in psychology and receive specialized training, along with ongoing supervision and coaching, to maintain high standards of professional development. This platform is designed to give employees quick access to mental health resources during times of crisis, fostering personal growth and overall well-being. By facilitating group sessions led by qualified professionals, Likeminded aims to improve employee satisfaction, retention, and productivity while also reducing absenteeism.

Diogenx

Series A in 2023
DiogenX is a preclinical stage biotech company based in Marseille, France, with research labs in Nice. Founded in 2019, the company specializes in developing therapeutic solutions for diabetic patients, focusing on pancreatic beta-cell modulators for the treatment of Type 1 and Type 2 diabetes. DiogenX aims to create a candidate molecule that regenerates insulin-producing pancreatic cells, potentially improving the quality of life and survival rates for individuals with diabetes. The innovative therapy is based on research conducted in the laboratory of Dr. Patrick Collombat, which positions DiogenX as a pioneer in the development of beta-cell regeneration treatments for diabetes.

qlub

Seed Round in 2023
Qlub offers a fast and secure payment solution designed specifically for the restaurant industry. Its platform enables restaurant, pub, and cafe owners to display their menus and accept payments in seconds. Customers can pay their bills quickly by scanning a QR code, allowing for a seamless transaction that takes about 10 seconds, all without the need to install an app or register. This efficiency enhances the dining experience for customers while improving workflow for staff, ultimately creating a more enjoyable atmosphere for all.

Teitur Trophics

Series A in 2023
Teitur Trophics is a biotech company based in Aarhus, Denmark, established in 2020. The company focuses on developing circular peptides aimed at addressing neurodegenerative diseases. By studying small peptides that interact with receptors crucial for neural function, Teitur Trophics aims to understand the underlying biology and modulate key mechanisms involved in neural activity. This research is intended to support healthcare professionals in creating treatments that can prevent the onset of neurodegenerative conditions through daily injections.

Quell

Series A in 2023
Quell, Inc. is a San Francisco-based company founded in 2020 that creates an immersive fitness experience combining gaming with physical workouts. The company offers a unique fitness game where players engage in combat within a fantasy world, utilizing low-cost wearable smart resistance bands to enhance their workouts at home. Quell positions itself as a blend of traditional fitness platforms and gaming, providing an innovative approach to achieving fitness goals. To maintain ongoing engagement, Quell charges a monthly subscription fee for access to fresh content and experiences.

Natural Cycles

Venture Round in 2023
Natural Cycles is a digital health company that provides a contraceptive app designed to empower women in managing their reproductive health. The app utilizes an algorithm to analyze users' basal body temperature and other relevant data, such as luteinizing hormone levels, to determine fertility status throughout the menstrual cycle. By requiring daily temperature measurements with a basal thermometer, the app generates a color-coded calendar that informs users of their fertile days, allowing for informed decisions regarding unprotected sex. This non-invasive and non-hormonal approach enables women to plan or prevent pregnancies while avoiding the side effects associated with traditional contraceptive methods. Natural Cycles is at the forefront of digital contraception, offering a modern solution to female fertility tracking.

MinervaX

Series C in 2022
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.

Ukio

Series A in 2022
Ukio operates an apartment rental platform that focuses on providing well-furnished, turnkey apartments for monthly stays. By offering a network of design-forward accommodations, Ukio aims to simplify the rental process, eliminating the challenges associated with traditional housing. Clients benefit from furnished and serviced apartments that allow for flexible living arrangements without the burden of long-term contracts, moving logistics, or additional costs such as security deposits and broker fees. This model combines the comforts of home with the conveniences typically associated with hotel stays, catering to individuals seeking a more adaptable housing solution.

Neoplants

Seed Round in 2022
Neoplants use synthetic biology to design plants for the future.

Orbex Space

Series C in 2022
Orbex is a space startup that develops orbital launch technology for small payload reusable satellites. Its technology is developed in-house, including rocket engines, avionics, GNC, software, and structure technologies to launch small, micro, and nano-satellites into low orbits. They offer a flexible core launch service and a wide suite of supporting services that make life easier for customers. Their European location means shorter supply lines, easier communications, and reduced operational costs. Their advanced launch vehicle means higher reliability, more flexible mission profiles, and a regular, scheduled launch service.

Kive

Seed Round in 2022
Kive is a Stockholm-based company founded in 2018 that specializes in developing an AI platform designed to help creatives manage visual assets. The platform utilizes machine learning to automatically categorize and organize these assets by various attributes, including styles, environments, objects, lighting, actions, faces, and types of shots. In addition to its organizational capabilities, Kive facilitates easy sharing of visual content, serving as both a portfolio and presentation tool while integrating with social media platforms. This functionality is particularly beneficial for filmmakers, designers, and e-commerce brands, allowing them to efficiently curate and present their work.

Gourmey

Series A in 2022
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.

Podimo

Series B in 2022
Podimo is an audio entertainment subscription company that focuses on creating an ecosystem for podcasters by compensating creators for their work. The platform offers a diverse range of podcasts, including popular shows and exclusive content from both established and emerging hosts. This variety allows users to access a wide selection of podcasts at their convenience, enhancing the listening experience. By prioritizing the needs of podcasters and fostering a supportive environment for content creation, Podimo aims to change the landscape of audio entertainment.

Fora

Series A in 2022
Fora is a modern travel agency focused on empowering travel entrepreneurs and enthusiasts by curating exceptional experiences for travelers. The company aims to support 100,000 travel entrepreneurs by providing personalized services that cater to individual travel styles. Fora assists clients in planning their trips from inception to booking, facilitating connections with advisors who understand their specific preferences and aspirations. This approach not only enhances the travel planning experience but also fosters a community of knowledgeable travel creators dedicated to delivering memorable journeys.

FINN

Series B in 2022
FINN is a car subscription service that aims to provide a sustainable alternative to traditional car ownership. The company offers monthly subscriptions that include all necessary services, allowing customers to enjoy the benefits of driving without the associated challenges and hidden costs of owning a vehicle. By focusing on transparency and convenience, FINN caters to individuals who appreciate the freedom of having their own car but seek a more flexible and hassle-free solution. The platform enables users to access vehicles on-demand, promoting a more sustainable approach to mobility.

zolar

Series C in 2022
ZOLAR GmbH, based in Berlin, Germany, specializes in designing, building, and providing customized residential solar and battery systems. Founded in 2016, the company offers a comprehensive online configurator that allows homeowners to tailor their photovoltaic systems to meet individual needs while receiving expert assistance. ZOLAR coordinates the installation process through a network of local partner companies, ensuring that each system is properly implemented. Employing around 200 individuals, ZOLAR aims to promote energy independence for households by facilitating the integration of energy generation, storage, and smart home solutions. The company encourages customers to produce their own green electricity, thereby reducing reliance on the mains grid and contributing to climate protection initiatives. Through its innovative approach, ZOLAR envisions a future where solar systems are installed on rooftops worldwide, empowering households to neutralize their carbon footprints.

HeyJobs

Series B in 2022
HeyJobs operates a talent acquisition platform designed to streamline and automate the employee recruitment process. By leveraging artificial intelligence and machine learning, the platform effectively identifies and matches candidates to job profiles, enhancing the hiring experience for both employers and job seekers. HeyJobs facilitates a personalized application and assessment flow, allowing employers to recruit skilled workers efficiently and at a lower cost compared to traditional hiring methods. Through its innovative approach, the company has successfully facilitated over 100,000 hires, helping individuals find fulfilling job opportunities while meeting the needs of employers seeking quality candidates.

TargED Biopharmaceuticals

Series A in 2022
TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Zefir

Series A in 2022
Zefir operates an online real estate marketplace designed to simplify the buying and selling of properties. By utilizing advanced valuation algorithms and automated processes, Zefir allows sellers to receive offers for their homes without the need for traditional listing or showing. This streamlined approach aims to make transactions more straightforward and efficient for customers, facilitating a simple and certain experience in real estate dealings.

qlub

Seed Round in 2022
Qlub offers a fast and secure payment solution designed specifically for the restaurant industry. Its platform enables restaurant, pub, and cafe owners to display their menus and accept payments in seconds. Customers can pay their bills quickly by scanning a QR code, allowing for a seamless transaction that takes about 10 seconds, all without the need to install an app or register. This efficiency enhances the dining experience for customers while improving workflow for staff, ultimately creating a more enjoyable atmosphere for all.

Kenbi

Series A in 2021
Kenbi is a nurse-centric outpatient care company focused on enhancing healthcare delivery by supporting nurses and addressing gaps in the system. It offers outpatient care management services that leverage technology and a collegial organizational structure to organize local care teams. These teams provide at-home services, which may include medical care covered by insurance, household assistance, advice, and companionship. By streamlining operations and reducing bureaucratic burdens, Kenbi enables healthcare practitioners to devote more time to patient care, thus improving the overall experience for patients and their families.

FORMEL Skin

Series A in 2021
FORMEL Skin is a healthtech start-up based in Berlin, Germany, founded in 2020. The company aims to transform dermatology by providing personalized, high-quality medical treatments through an online platform. FORMEL Skin offers a range of medical and science-based solutions designed to address various dermatological conditions. Its approach involves thorough consultations with dermatologists, ensuring that products are tailored to individual skin types and needs. This personalized treatment plan enables patients with skin issues to receive effective care that is specifically suited to their circumstances.

MAJORITY

Series A in 2021
MAJORITY is a fintech company that provides an app-based platform tailored for migrants seeking accessible financial services. For a monthly fee, members in the United States gain access to essential banking features, including an FDIC-secured account and a VISA debit card. The platform allows users to utilize over 55,000 ATMs across North America and offers services such as remittances, international calling, and mobile top-ups. Additionally, MAJORITY emphasizes community engagement by providing access to local meet-up spaces, discounts, and events, along with support from advisors fluent in various native languages. This comprehensive approach aims to address the unique financial needs of individuals who have crossed borders.

Podimo

Series B in 2021
Podimo is an audio entertainment subscription company that focuses on creating an ecosystem for podcasters by compensating creators for their work. The platform offers a diverse range of podcasts, including popular shows and exclusive content from both established and emerging hosts. This variety allows users to access a wide selection of podcasts at their convenience, enhancing the listening experience. By prioritizing the needs of podcasters and fostering a supportive environment for content creation, Podimo aims to change the landscape of audio entertainment.

Fora

Seed Round in 2021
Fora is a modern travel agency focused on empowering travel entrepreneurs and enthusiasts by curating exceptional experiences for travelers. The company aims to support 100,000 travel entrepreneurs by providing personalized services that cater to individual travel styles. Fora assists clients in planning their trips from inception to booking, facilitating connections with advisors who understand their specific preferences and aspirations. This approach not only enhances the travel planning experience but also fosters a community of knowledgeable travel creators dedicated to delivering memorable journeys.

Luca

Pre Seed Round in 2021
Luca is an educational startup focused on providing a learning platform for primary and secondary students in Spanish-speaking Latin American countries. The platform features pre-recorded K12 videos, gamified content, and AI-powered personalized study paths, all designed to align with the official academic curriculum and prepare students for national exams. By employing diverse learning techniques, Luca aims to democratize education and enhance students' study habits, ultimately improving their learning routines. The company is headquartered in Mexico City, with additional offices in Lisbon and Madrid.

Ukio

Seed Round in 2021
Ukio operates an apartment rental platform that focuses on providing well-furnished, turnkey apartments for monthly stays. By offering a network of design-forward accommodations, Ukio aims to simplify the rental process, eliminating the challenges associated with traditional housing. Clients benefit from furnished and serviced apartments that allow for flexible living arrangements without the burden of long-term contracts, moving logistics, or additional costs such as security deposits and broker fees. This model combines the comforts of home with the conveniences typically associated with hotel stays, catering to individuals seeking a more adaptable housing solution.

Corti

Series A in 2021
Corti is an artificial intelligence platform focused on improving medical triaging through advanced voice-based technology. It enhances patient interactions by analyzing interviews and preparing case files prior to consultations. By utilizing proprietary speech recognition and natural language processing, Corti helps healthcare providers understand patient situations more effectively. The platform also suggests relevant questions to ask during consultations, aiming to reduce errors and increase the accuracy of clinical decisions. Trusted by leading healthcare providers, Corti integrates seamlessly into existing workflows, ultimately striving to save more lives by enabling faster and more precise decision-making in medical care.

Scapin'

Pre Seed Round in 2021
Scapin' building the next generations' social communications platform.

Gourmey

Seed Round in 2021
Gourmey is a cultivated meat company based in Paris, France, founded in 2019. It specializes in producing ethical foie gras derived from duck cells, offering a sustainable alternative to traditional methods that involve force-feeding and slaughter. By cultivating animal cells in a controlled laboratory environment, Gourmey creates meat products that prioritize health, environmental sustainability, and animal welfare. The company aims to provide delicious meat options for consumers who are conscious of their choices and seek innovative solutions in the food industry.

Front of The Pack

Series A in 2021
Front of The Pack is a producer and seller of dog supplements designed to enhance the health and well-being of pets. The company offers a range of products that aim to improve dental health, alleviate joint pain, and promote healthy, shiny coats in dogs. By focusing on the nutritional needs of pets, Front of The Pack provides a straightforward and effective solution for pet owners seeking to support their dogs' health through quality supplements.

Kobaj

Pre Seed Round in 2021
Kobaj provides co-buying, community, e-commerce, winemakers, wine, platform, and marketplace services. They also provide beverage manufacturing, payment, fees, insurance, and transport of the goods.

Layerise

Seed Round in 2021
Layerise is a developer of product onboarding software aimed at enhancing customer experiences. The company offers a platform that simplifies product registration with a one-tap feature, while also creating interactive and intelligent product assistants. This technology focuses on transforming traditional product instructions into engaging customer experiences. By facilitating effective communication and support, Layerise enables businesses to elevate their customer service, turning standard transactions into positive sales experiences.

Forecast

Series A in 2021
The Forecast AI-native platform represents the most advanced technology ever applied to managing projects, resources and finances. Our platform automates busywork, surfaces best practices, predicts outcomes, guides projects to success, and most importantly empowers every team member to do their best work. Forecast is the ultimate upgrade for project teams and professional services organizations. Technology doing what it does best, so humans can do what they do best.

TravelPerk

Series D in 2021
TravelPerk is a comprehensive platform that streamlines business travel management by integrating booking, reporting, and support into a single tool. It enables users to easily book flights, hotels, and car rentals while ensuring adherence to company policies. The platform offers a wide range of travel options and features, including automated policies, expense integrations, and customer service support. With its user-friendly interface and advanced technology, TravelPerk helps organizations manage their travel needs efficiently, control costs, and simplify the overall booking process for employees. By combining various travel services into one solution, it aims to enhance the travel experience for businesses and reduce the complexities associated with managing business trips.

Taster

Series B in 2021
Taster is a food incubator focused on transforming the quick-service food sector for modern consumers. The company collaborates with talented culinary creators to develop and scale delivery-only food brands, emphasizing quality and taste. By leveraging a comprehensive digital restaurant platform, Taster enables restaurant owners to operate successful delivery-focused kitchens that provide a diverse array of cuisines. Additionally, Taster fosters a community of local entrepreneurs through its franchise network, creating economic opportunities in various markets. The emphasis on efficient delivery and collection from dedicated locations allows Taster to meet the growing demand for convenient dining options.

Kaia Health

Series C in 2021
Kaia Health is a digital therapeutics company that specializes in developing evidence-based treatments for various disorders, including back pain and chronic obstructive pulmonary disease (COPD). Founded in 2016 and headquartered in Brooklyn, New York, the company utilizes machine learning to provide personalized app interventions designed to empower patients in self-managing their conditions from home using familiar devices like smartphones and tablets. Kaia Health's platform delivers tailored daily plans that incorporate exercises, relaxation techniques, and educational content, allowing users to customize their programs according to personal preferences. To date, the company has enrolled over 400,000 users in its digital therapy program.

Likeminded

Seed Round in 2021
Likeminded is a digital platform focused on mental health, offering a variety of courses aimed at enhancing mental well-being. The platform provides both individual and group sessions, along with on-demand support, to meet the diverse needs of users. Trained psychotherapists, psychologists, and coaches deliver these services, ensuring a comprehensive approach to mental health care. The experts at Likeminded possess academic backgrounds in psychology and receive specialized training, along with ongoing supervision and coaching, to maintain high standards of professional development. This platform is designed to give employees quick access to mental health resources during times of crisis, fostering personal growth and overall well-being. By facilitating group sessions led by qualified professionals, Likeminded aims to improve employee satisfaction, retention, and productivity while also reducing absenteeism.

Zefir

Seed Round in 2021
Zefir operates an online real estate marketplace designed to simplify the buying and selling of properties. By utilizing advanced valuation algorithms and automated processes, Zefir allows sellers to receive offers for their homes without the need for traditional listing or showing. This streamlined approach aims to make transactions more straightforward and efficient for customers, facilitating a simple and certain experience in real estate dealings.

Step Pharma

Series B in 2021
Step Pharma, established in 2014 and based in Paris, France, focuses on developing innovative small molecule therapeutics for immunosuppressive therapies aimed at treating autoimmune diseases. As a spin-off from the Imagine Institute, the company leverages research on genetic immunodeficiencies conducted by Pr. Alain Fischer. Step Pharma operates as a joint venture with contributions from Imagine, Sygnature Discovery, and Kurma Partners, combining expertise in drug discovery and funding within the healthcare and biotechnology sectors. The company's proprietary therapeutics utilize a novel class of oral nucleotide synthesis inhibitors that specifically target cytidine triphosphate synthase 1 (CTPS1). This targeted approach enables selective modulation of immune cell populations, such as T and B cells, leading to enhanced treatment efficacy and improved therapeutic outcomes for patients with autoimmune conditions.

Roadsurfer

Series A in 2021
Roadsurfer is a camper rental company based in Munich, Germany, that was established in 2017. It operates a platform offering over 2,500 campervans for rent across more than 22 locations in several European countries, including Germany, France, Spain, and Portugal. The company focuses on providing a wide selection of campervans equipped with essential amenities such as beds, kitchen utensils, and outdoor gear, ensuring travelers can enjoy a comfortable and safe camping experience. In addition to its rental services, Roadsurfer assists customers in easily booking individual camping spots in picturesque outdoor settings through an online platform, allowing for greater freedom and flexibility in exploring various destinations.

Ascelia Pharma

Post in 2021
Ascelia Pharma is a biotechnology company based in Malmö, Sweden, specializing in drug development for orphan oncology treatments. The company is dedicated to addressing unmet medical needs in the oncology sector by developing and commercializing innovative therapies. Ascelia Pharma has two drug candidates currently in clinical development: Orviglance and Oncoral. These candidates are designed to provide new options for patients with specific cancer types, reflecting the company's commitment to improving outcomes in underserved patient populations.

Weezy

Series A in 2021
Weezy is an online supermarket platform based in London, England, that specializes in on-demand grocery shopping. Founded in 2019, it allows users to conveniently browse and order a wide variety of products, including groceries, snacks, drinks, home essentials, and over-the-counter pharmaceuticals, all from their mobile devices. The application streamlines the shopping experience by enabling users to discover and purchase their daily needs with just a single tap, ensuring quick delivery to their doorsteps.

Lovys

Series A in 2021
Lovys is a digital insurance provider based in France, founded in 2017. It is recognized as the first fully digital, all-in-one insurance platform in the country. Lovys aims to simplify the insurance experience by offering a personalized and transparent interface where users can manage their insurance needs through a single monthly subscription. The company's application allows clients to register and insure individual items with ease, providing clear insights into costs and facilitating direct management of policies and claims. By rethinking the traditional insurance model, Lovys is dedicated to making insurance simpler and more accessible for users.

Exporo

Venture Round in 2021
Exporo offers investors an overview of real estate projects in which they can invest easily, transparently and free of charge. The idea begins in 2013 with the realization that real estate project developers are increasingly looking for alternative sources of finance, as banks no longer finance entire projects as usual due to stricter regulation, and that private investors only have a lot of money, with good conditions and easy to invest in real estate. The result of this observation is the firm decision to develop its own online marketplace to offer real estate projects as an investment opportunity and to provide capital directly between private investors and real estate companies. Simon Brunke, Björn Maronde, Tim Bütecke and Julian Oertzen founded the online platform in 2014, they are constantly evolving and they are board members of Exporo AG. The company now employs more than 120 people and is based in Hamburg's HafenCity.

IO Biotech

Series B in 2021
IO Biotech is a clinical-stage biopharmaceutical company focused on developing innovative immune therapies for cancer treatment. Utilizing its proprietary T-win technology platform, the company creates immune-modulating cancer vaccines that activate T cells specifically targeting immune-suppressive molecules. This approach aims to induce the immune system to disrupt multiple pathways responsible for tumor-induced immunosuppression. IO Biotech has a solid track record in advancing both preclinical and clinical compounds, with its two lead candidates targeting IDO and PD-L1 currently in clinical development, while several additional therapies remain in the preclinical stage.

Kenbi

Seed Round in 2021
Kenbi is a nurse-centric outpatient care company focused on enhancing healthcare delivery by supporting nurses and addressing gaps in the system. It offers outpatient care management services that leverage technology and a collegial organizational structure to organize local care teams. These teams provide at-home services, which may include medical care covered by insurance, household assistance, advice, and companionship. By streamlining operations and reducing bureaucratic burdens, Kenbi enables healthcare practitioners to devote more time to patient care, thus improving the overall experience for patients and their families.

Ninety Nine

Venture Round in 2021
Ninety Nine is a developer of a financial trading platform that offers commission-free trading services. The platform is designed to enhance users' relationships with their money by providing a seamless investment experience. It features tools that allow users to curate a list of relevant companies and access news, articles, and educational content related to various investments. This approach enables customers to make informed decisions about their investments without incurring fees, while also fostering financial literacy through its educational resources.

Donut

Venture Round in 2021
Donut helps people discover new ways to build wealth, by providing the easiest and most trusted way to save & earn high yield with DeFi.

MinervaX

Series B in 2020
Minervax is focused on developing a vaccine to prevent infections caused by Group B streptococcus (GBS), which can lead to serious health issues in newborns and adverse pregnancy outcomes. The company is researching a specific fusion protein that has demonstrated the ability to stimulate strong protective immunity against various clinically significant GBS strains. By utilizing this innovative approach, Minervax aims to provide medical professionals with an effective tool to protect newborns from potentially life-threatening bacterial infections associated with GBS.

Tink

Venture Round in 2020
Tink is a cloud-based open banking platform that provides the infrastructure and value-adding data products that are enabling the future of financial services. Tink offers products such as account aggregation, payment initiation, data enrichment, and personal finance management that can be used to develop standalone services or be integrated into existing banking applications. Its partners include ABN AMRO, BNP Paribas Fortis, Nordea, Klarna, and SEB. Tink was founded in 2012 and is based in Stockholm, Sweden.

Orbex Space

Venture Round in 2020
Founded in 2015, Orbex is a leading private launch services company in Europe, specializing in the small satellite industry. The company has developed a low carbon, high-performance micro-launch vehicle that supports the deployment of satellites into polar and sun-synchronous low Earth orbits from a modern launch site in central Europe. Orbex offers a flexible core launch service along with a range of supporting services aimed at simplifying the launch process for its customers. By operating from a European location, Orbex benefits from shorter supply lines, easier communication, and reduced operational costs. The company utilizes advanced materials and in-house technologies, including rocket engines and avionics, to ensure high reliability and flexible mission profiles, enabling timely launches for small, micro, and nano-satellites.

FORMEL Skin

Seed Round in 2020
FORMEL Skin is a healthtech start-up based in Berlin, Germany, founded in 2020. The company aims to transform dermatology by providing personalized, high-quality medical treatments through an online platform. FORMEL Skin offers a range of medical and science-based solutions designed to address various dermatological conditions. Its approach involves thorough consultations with dermatologists, ensuring that products are tailored to individual skin types and needs. This personalized treatment plan enables patients with skin issues to receive effective care that is specifically suited to their circumstances.

FINN

Series A in 2020
FINN is a car subscription service that aims to provide a sustainable alternative to traditional car ownership. The company offers monthly subscriptions that include all necessary services, allowing customers to enjoy the benefits of driving without the associated challenges and hidden costs of owning a vehicle. By focusing on transparency and convenience, FINN caters to individuals who appreciate the freedom of having their own car but seek a more flexible and hassle-free solution. The platform enables users to access vehicles on-demand, promoting a more sustainable approach to mobility.

Quell

Seed Round in 2020
Quell, Inc. is a San Francisco-based company founded in 2020 that creates an immersive fitness experience combining gaming with physical workouts. The company offers a unique fitness game where players engage in combat within a fantasy world, utilizing low-cost wearable smart resistance bands to enhance their workouts at home. Quell positions itself as a blend of traditional fitness platforms and gaming, providing an innovative approach to achieving fitness goals. To maintain ongoing engagement, Quell charges a monthly subscription fee for access to fresh content and experiences.

Synendos Therapeutics

Series A in 2020
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain. The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need.

Galecto

Series D in 2020
Galecto is a clinical-stage biotechnology company focused on developing small molecules to treat severe diseases, particularly fibrosis and cancer. The company’s lead product candidate, GB0139, is an inhaled inhibitor of galectin-3 aimed at addressing severe fibrotic lung diseases, including idiopathic pulmonary fibrosis, which presents a significant unmet medical need. Founded in 2011, Galecto builds upon more than a decade of research into the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic diseases. The company also develops additional therapeutics, such as GB1211, a selective oral galectin-3 inhibitor targeting fibrosis related to non-alcoholic steatohepatitis. Galecto's strong patent portfolio and research foundation position it uniquely within the therapeutic landscape for fibrosis and related diseases.

Layerise

Pre Seed Round in 2020
Layerise is a developer of product onboarding software aimed at enhancing customer experiences. The company offers a platform that simplifies product registration with a one-tap feature, while also creating interactive and intelligent product assistants. This technology focuses on transforming traditional product instructions into engaging customer experiences. By facilitating effective communication and support, Layerise enables businesses to elevate their customer service, turning standard transactions into positive sales experiences.

Front of The Pack

Seed Round in 2020
Front of The Pack is a producer and seller of dog supplements designed to enhance the health and well-being of pets. The company offers a range of products that aim to improve dental health, alleviate joint pain, and promote healthy, shiny coats in dogs. By focusing on the nutritional needs of pets, Front of The Pack provides a straightforward and effective solution for pet owners seeking to support their dogs' health through quality supplements.

zolar

Series B in 2020
ZOLAR GmbH, based in Berlin, Germany, specializes in designing, building, and providing customized residential solar and battery systems. Founded in 2016, the company offers a comprehensive online configurator that allows homeowners to tailor their photovoltaic systems to meet individual needs while receiving expert assistance. ZOLAR coordinates the installation process through a network of local partner companies, ensuring that each system is properly implemented. Employing around 200 individuals, ZOLAR aims to promote energy independence for households by facilitating the integration of energy generation, storage, and smart home solutions. The company encourages customers to produce their own green electricity, thereby reducing reliance on the mains grid and contributing to climate protection initiatives. Through its innovative approach, ZOLAR envisions a future where solar systems are installed on rooftops worldwide, empowering households to neutralize their carbon footprints.

SoundBoks

Venture Round in 2020
SoundBoks is a hardware start-up founded in January 2015, with headquarters in Mountain View, California, and an additional office in San Francisco. The company specializes in designing and manufacturing battery-powered outdoor speakers, which are particularly suited for outdoor gatherings, sports events, and festivals. Known for their shock and weatherproof construction, SoundBoks speakers are portable and durable, offering up to 60 hours of battery life at high volumes. The speakers feature high sound pressure level (SPL) units paired with a powerful amplifier, capable of reaching sound outputs of up to 119 decibels. SoundBoks aims to enhance outdoor music experiences, allowing users to take their sound systems anywhere.

Weezy

Pre Seed Round in 2020
Weezy is an online supermarket platform based in London, England, that specializes in on-demand grocery shopping. Founded in 2019, it allows users to conveniently browse and order a wide variety of products, including groceries, snacks, drinks, home essentials, and over-the-counter pharmaceuticals, all from their mobile devices. The application streamlines the shopping experience by enabling users to discover and purchase their daily needs with just a single tap, ensuring quick delivery to their doorsteps.

TrapLight Games

Venture Round in 2020
Traplight creates ultra approachable and deep F2P games. From the first seconds their games offer you fun, effortless gameplay and a deep, empowering progression. They focus on creating entertainment that lasts for years and is always fresh. Players are the ones they create their games for, not us. This drives us to make fun, empowering and coherent gaming experiences that their players truly want. Founded in 2010 and based in Tampere, Finland, Traplight currently has a 28 strong team working on several games. Traplight’s team and vision have been backed up by renowned game investors such as Initial Capital, Korea Investment Partners, Sunstone Capital and Finnvera Venture Capital. Traplight’s Big Bang Racing was chosen as Best of 2016 in AppStore, and currently the company is preparing to soft launch their next big hit soon.

Kaia Health

Series B in 2020
Kaia Health is a digital therapeutics company that specializes in developing evidence-based treatments for various disorders, including back pain and chronic obstructive pulmonary disease (COPD). Founded in 2016 and headquartered in Brooklyn, New York, the company utilizes machine learning to provide personalized app interventions designed to empower patients in self-managing their conditions from home using familiar devices like smartphones and tablets. Kaia Health's platform delivers tailored daily plans that incorporate exercises, relaxation techniques, and educational content, allowing users to customize their programs according to personal preferences. To date, the company has enrolled over 400,000 users in its digital therapy program.

Podimo

Series A in 2020
Podimo is an audio entertainment subscription company that focuses on creating an ecosystem for podcasters by compensating creators for their work. The platform offers a diverse range of podcasts, including popular shows and exclusive content from both established and emerging hosts. This variety allows users to access a wide selection of podcasts at their convenience, enhancing the listening experience. By prioritizing the needs of podcasters and fostering a supportive environment for content creation, Podimo aims to change the landscape of audio entertainment.

BLAST Premier

Venture Round in 2020
BLAST Premier is an esports entertainment company that specializes in broadcast studio shows, arena events, and online content.

IO Biotech

Debt Financing in 2020
IO Biotech is a clinical-stage biopharmaceutical company focused on developing innovative immune therapies for cancer treatment. Utilizing its proprietary T-win technology platform, the company creates immune-modulating cancer vaccines that activate T cells specifically targeting immune-suppressive molecules. This approach aims to induce the immune system to disrupt multiple pathways responsible for tumor-induced immunosuppression. IO Biotech has a solid track record in advancing both preclinical and clinical compounds, with its two lead candidates targeting IDO and PD-L1 currently in clinical development, while several additional therapies remain in the preclinical stage.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.